Literature DB >> 16502285

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.

H Liang1, X He, R X Shen, T Shen, X Tong, Y Ma, W H Xiang, X Y Zhang, Y M Shao.   

Abstract

The Chinese equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) provides a unique natural model system to study the attenuation mechanism and immunological control of lentivirus replication. Critical consensus mutations were identified between virulent Chinese EIAV strains and vaccine strains. Based on a full-length infectious clone of EIAV vaccine strain pLGFD3, two molecular clones, mFD5-4-7 and mFD7-2-11, were successfully constructed, in which 4 and 6 critical consensus mutations in the env gene of the vaccine strain were point-mutated to the wild-type sequence, respectively by an overlap PCR mutagenesis strategy. The infectivity, virulence, and pathogenesis of the constructed clones were investigated in vitro using a reverse transcriptase assay, an indirect immunofluorescence assay, observation of cytopathogenic effect, and virion observation as well as in vivo by inoculation of animals with the resulting infectious clones. The pathogenic symptoms in horses inoculated with mFD7-2-11 were more severe than those inoculated with mFD5-4-7, whereas no pathogenic symptoms were detected in animals inoculated with their parental clone pLGFD3 strain. The results indicate that the consensus mutation residues of the env region involved in this study play significant roles in the virulence and pathogenicity of EIAV. This will contribute to the elucidation of the attenuating and protective mechanisms of the Chinese EIAV vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502285     DOI: 10.1007/s00705-005-0718-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

1.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

2.  Cloning, expression and preliminary crystallographic analysis of the equine infectious anaemia virus (EIAV) gp45 ectodomain.

Authors:  Pei Long Sun; Shu Xia Lv; Jian Hua Zhou; Xin Qi Liu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-03-25

Review 3.  Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.

Authors:  Liangwei Duan; Jiansen Du; Xinqi Liu
Journal:  Protein Sci       Date:  2015-09-21       Impact factor: 6.725

4.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

5.  Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.

Authors:  Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Fenglong Wang; Rongxian Shen; Jianhua Zhou
Journal:  Virus Genes       Date:  2011-01-08       Impact factor: 2.332

6.  The comparison of genetic variation in the envelope protein between various immunodeficiency viruses and equine infectious anemia virus.

Authors:  Qing Yuan; Chang Liu; Zhipin Liang; Xueqing Chen; Danhong Diao; Xiaohong Kong
Journal:  Virol Sin       Date:  2012-07-28       Impact factor: 4.327

7.  Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.

Authors:  Xiue Han; Ping Zhang; Wei Yu; Wenhua Xiang; Xiaodong Li
Journal:  Virus Genes       Date:  2016-08-29       Impact factor: 2.332

8.  A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.

Authors:  Qinglai Meng; Yuezhi Lin; Jian Ma; Yan Ma; Liping Zhao; Shenwei Li; Kai Yang; Jianhua Zhou; Rongxian Shen; Xiaoyan Zhang; Yiming Shao
Journal:  Viral Immunol       Date:  2012-11-21       Impact factor: 2.257

9.  Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.

Authors:  Lianxing Liu; Yanmin Wan; Lan Wu; Jianping Sun; Huiguang Li; Haishan Li; Liying Ma; Yiming Shao
Journal:  Retrovirology       Date:  2010-09-01       Impact factor: 4.602

10.  Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.

Authors:  Jiansen Du; Xuefeng Wang; Jing Ma; Jianxin Wang; Yuyin Qin; Chunhui Zhu; Fang Liu; Yiming Shao; Jianhua Zhou; Wentao Qiao; Xinqi Liu
Journal:  Retrovirology       Date:  2014-03-21       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.